Estrella Immunopharma, Inc. ESLA Q1 2026 Annual earnings
Reported May 15, 2026 · Before market open
EPS-$0.05Beat by $0.03
EPS estimate-$0.08
Next report
Sep 2, 2026 (in a month)EPS estimate-$0.09
Versus estimates
Diluted EPS
Ask the moment Estrella Immunopharma, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Estrella Immunopharma, Inc. report Q1 2026 earnings?
- Estrella Immunopharma, Inc. (ESLA) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Estrella Immunopharma, Inc.'s Q1 2026 revenue and EPS?
- Estrella Immunopharma, Inc. reported eps of $-0.05 for Q1 2026.
- Did Estrella Immunopharma, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.08 by $0.03.
- How did Estrella Immunopharma, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 16.7% from $-0.06.
- Where can I find Estrella Immunopharma, Inc.'s Q1 2026 SEC filings?
- You can read the 10-K/A periodic report (0001213900-26-050433) directly on SEC EDGAR. The filing index links above go to sec.gov.